A unified health data AI platform for longevity

Biolytica CEO on the importance of using combined health data and AI in longevity to enable personalised and preventive health to flourish.?

Swiss start-up?Biolytica?has launched a longevity health data platform, giving healthcare and longevity professionals a tool to help them optimise personalised and preventive health plans for clients and patients. The Biolytica NEXUS platform brings together data from multiple sources – genomics, pharmacogenomics, epigenetics, biomarkers, wearable-devices, lifestyle, nutrition, and many others – using AI analysis to deliver unique healthspan and longevity insights.

My take on this: Biolytica is one of the first companies to emerge from Swiss longevity company builder?Maximon. With its sharp focus on data, it tackles some of the biggest questions facing the field – everyone is unique, so what should each of us, specifically, be doing to boost our healthspan? How do we personalise longevity and preventive health? We caught up with Biolytica’s CEO Dr Rob Konrad to learn more about the company’s approach.

The driving principle at the core of Biolytica is the unification and analysis of the growing amounts of health data that are now being collected across a wide range of health areas.

“We have so much data available to us: genomics and pharmacogenomics; epigenetics; all the labs, biomarkers, microbiota,” says Konrad. “We have new aging clocks, data from wearable devices that everyone is wearing, personal historical health data, and everything else. All of this?should?allow us to deliver more personalised, preventive healthcare, and recommend longevity related interventions.”

Read the full article HERE.

Thanks for reading! If you’ve enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!